Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.75B |
| 2 |
NVIDIA
NVDA
|
+$1.34B |
| 3 |
Capital One
COF
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$1.01B |
| 5 |
Amazon
AMZN
|
+$813M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$496M |
| 4 |
Qualcomm
QCOM
|
+$469M |
| 5 |
Applovin
APP
|
+$390M |
Sector Composition
| 1 | Technology | 32.48% |
| 2 | Financials | 14.03% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Quantum Corp
QMCO
$114M
| $692K | ﹤0.01% |
69,384
+5,806
| +9% | +$57.9K |
|
3452
MediciNova
MNOV
$62.3M
| $689K | ﹤0.01% |
525,892
-1,107
| -0.2% | -$1.45K |
|
3453
Brookfield Infrastructure Partners
BIP
$14.2B
| $687K | ﹤0.01% |
18,624
-810
| -4% | -$29.9K |
|
3454
Northern Technologies International Corp
NTIC
$74.8M
| $687K | ﹤0.01% |
92,626
-94,908
| -51% | -$703K |
|
3455
Children's Place
PLCE
$170M
| $685K | ﹤0.01% |
154,654
+5,630
| +4% | +$24.9K |
|
3456
Duos Technologies
DUOT
$139M
| $684K | ﹤0.01% |
95,682
+26,821
| +39% | +$192K |
|
3457
PSQ Holdings
PSQH
$90.4M
| $683K | ﹤0.01% |
333,355
+38,391
| +13% | +$78.7K |
|
3458
INNOVATE Corp
VATE
$65.3M
| $682K | ﹤0.01% |
132,303
+137
| +0.1% | +$706 |
|
3459
Immunic
IMUX
$86M
| $680K | ﹤0.01% |
974,636
-1,516
| -0.2% | -$1.06K |
|
3460
Tevogen Bio Holdings
TVGN
$172M
| $678K | ﹤0.01% |
542,025
+55,631
| +11% | +$69.5K |
|
3461
Pliant Therapeutics
PLRX
$104M
| $676K | ﹤0.01% |
582,586
-770,457
| -57% | -$894K |
|
3462
First Northwest Bancorp
FNWB
$62M
| $675K | ﹤0.01% |
87,687
-855
| -1% | -$6.59K |
|
3463
Neumora Therapeutics
NMRA
$264M
| $673K | ﹤0.01% |
916,815
-1,059,487
| -54% | -$777K |
|
|
EFXT
3464
Enerflex
EFXT
$1.26B
| $665K | ﹤0.01% |
83,987
+18,434
| +28% | +$146K |
|
3465
BGSF Inc
BGSF
$71.8M
| $665K | ﹤0.01% |
104,323
+321
| +0.3% | +$2.05K |
|
3466
GoHealth
GOCO
$75.9M
| $660K | ﹤0.01% |
118,961
+4,955
| +4% | +$27.5K |
|
3467
XBiotech
XBIT
$85.4M
| $656K | ﹤0.01% |
220,679
-240,551
| -52% | -$715K |
|
3468
TELA Bio
TELA
$62.2M
| $656K | ﹤0.01% |
337,945
-8,723
| -3% | -$16.9K |
|
3469
Quince Therapeutics
QNCX
$86.5M
| $655K | ﹤0.01% |
396,982
+1,272
| +0.3% | +$2.1K |
|
3470
Assertio
ASRT
$77.5M
| $655K | ﹤0.01% |
1,021,383
-86,310
| -8% | -$55.4K |
|
3471
Hennessy Advisors
HNNA
$91.7M
| $654K | ﹤0.01% |
51,894
+1,014
| +2% | +$12.8K |
|
|
SA
3472
Seabridge Gold
SA
$1.8B
| $652K | ﹤0.01% |
44,686
+3,982
| +10% | +$58.1K |
|
|
SACH
3473
Sachem Capital Corp
SACH
$60.6M
| $650K | ﹤0.01% |
541,298
-1,411
| -0.3% | -$1.69K |
|
3474
Auburn National Bancorp
AUBN
$85.6M
| $647K | ﹤0.01% |
24,959
-9
| -0% | -$233 |
|
|
OMDA
3475
Omada Health, Inc. Common Stock
OMDA
$1.24B
| $637K | ﹤0.01% |
+34,798
| New | +$637K |
|